AXS-07 for migraine, NDA submission (2Q 2021) AXS-05 for smoking cessation, FDA meeting (3Q 2021) AXS-05 for MDD, commercial launch, if approved (2H 2021) Clinical Trial Readouts: Clinical Trial Initiations: Upcoming Scientific Conferences International Society for Pharmacoeconomics and Outcomes Research (ISPOR) annual meeting, May 17-20, 2021 American Society for Clinical Psychopharmacology (ASCP) annual meeting, June 1-4, 2021 American Headache Society (AHS) annual meeting, June 3-6, 2021 Upcoming Investor Conferences BofA Health Care Conference, May 11, 2021 (to be webcast) RBC Capital Markets Global Healthcare Conference, May 18, 2021 (to be webcast) UBS Global Healthcare Virtual Conference, May 24, 2021 (to be webcast) William Blair Growth Stock Conference, June 3, 2021 (to be webcast) First Quarter 2021 Financial Results